Severe clinical course of de novo hepatitis B infection after liver transplantation

Liver Transplantation and Surgery

Volumn 5, Issue 3, 1999, Pages 175-183

  Crespo, J ^a   Fabrega, E ^a   Casafont, F ^a   Rivero, M ^a   De las Heras, G ^a   De la Pena, J ^a   De la Cruz, F ^a   Pons Romero, F ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CYCLOSPORIN; HEPATITIS B SURFACE ANTIGEN; IMMUNOSUPPRESSIVE AGENT; LAMIVUDINE; PREDNISOLONE; VIRUS DNA; ZIDOVUDINE;

ADULT; ARTICLE; CHRONIC HEPATITIS; DISEASE COURSE; GRAFT REJECTION; HEPATITIS B; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; NONHUMAN; ORGAN TRANSPLANTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS DETECTION;

EID: 0032915957     PISSN: 10743022     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.500050301     Document Type: Article

References (31)

1. 1 Samuel D, Muller R, Alexander G, Fassati L, Ducot B, Benahmou J‐P, et al. Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med 1993 ; 329: 1842–1847. MEDLINE
2. 2 Todo S, Demetris AJ, Van Thiel D, Teperman L, Fung JJ, Starzl TE. Orthotopic liver transplantation for patients with hepatitis B virus–related liver disease. Hepatology 1991 ; 13: 619–626. MEDLINE
3. 3 Ho BM, So SK, Esquivel CO, Keeffe EB. Liver transplantation in Asian patients with chronic hepatitis B. Hepatology 1997 ; 25: 223–225. MEDLINE
4. 4 Dickson RC, Everhart JE, Lake JR, Wei Y, Seaberg EC, Wiesner RH, et al. Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. Gastroenterology 1997 ; 113: 1668–1674. MEDLINE
5. 5 Roche B, Samuel D, Gigou M, Feray C, Virot V, Schmets L, et al. De novo and apparent de novo hepatitis B virus infection after liver transplantation. J Hepatol 1997 ; 26: 517–526. MEDLINE
6. 6 Chazouilléres O, Mamish D, Kim M, Carey K, Ferrel L, Roberts JP, et al. “Occult” hepatitis B virus as source of infection in liver transplant recipients. Lancet 1994 ; 343: 142–146. MEDLINE
7. 7 Fabia R, Levey MF, Crippin J, Tillery W, Netto GJ, Aguanno J, et al. De novo hepatitis B infection after liver transplantation: Source of disease, incidence and impact. Liver Transpl Surg 1988 ; 5: 119–124. MEDLINE
8. 8 Douglas DD, Rakela J, Wright TL, Krom RAF, Wiesner RH. The clinical course of transplantation‐associated de novo hepatitis B infection in liver transplant recipients. Liver Transpl Surg 1997 ; 3: 105–111. MEDLINE
9. 9 Safardi R, Edid A, Llan Y, Ashur Y, Jurim O, Shouval D. Natural course of de novo hepatitis B virus infection in liver transplant recipients. Transplant Proc 1997 ; 29: 2677–2679. MEDLINE
10. 10 Theilmann L, Arnold J, Tšx U, Datsis K, Otto G, Hofmann W, et al. Liver transplantation and de novo hepatitis B infection. Lancet 1994 ; 343: 677–678. MEDLINE
11. 11 Aldersley MA, Eglin RE, O'Grady JG. Liver transplantation and de novo hepatitis B infection. Lancet 1994 ; 343: 677. MEDLINE
12. 12 Cavallari A, De Raffele E, Bellusci R, Miniero R, Vivarelli M, Galli S, et al. De novo hepatitis B and C viral infection after liver transplantation. World J Surg 1997 ; 21: 78–85. MEDLINE
13. 13 Liu PP, Chen CL, Chen YS, Tai DI. De novo hepatitis B virus infection after orthotopic liver transplantation. Transplant Proc 1996 ; 28: 1684–1686. MEDLINE
14. 14 Mortiboy D, Davison S, George RH. Liver transplantation and de novo hepatitis B infection. Lancet 1994 ; 343: 677. MEDLINE
15. 15 Sanger F, Nicken S, Coulson AR. DNA sequencing chain‐termination inhibitor. Proc Natl Acad Sci U S A 1977 ; 74: 5447–5457.
16. 16 Crespo J, Lozano JL, Carte B, de las Heras B, de la Cruz F, Pons‐Romero F. Viral replication in patients with concomitant hepatitis B and C virus infection. Eur J Clin Microbiol Infect Dis 1997 ; 16: 445–451. MEDLINE
17. 17 Crespo J, Carte B, Lozano JL, Casafont F, Rivero M, de la Cruz F, Pons‐Romero F. Hepatitis C virus recurrence after liver transplantation: Relationship to anti‐HCV core IgM, genotype, and level of viremia. Am J Gastroenterol 1997 ; 92: 1458–1462. MEDLINE
18. 18 Kwock S, Higuchi R. Avoiding false‐positives with PCR. Nature 1989 ; 86: 312–316.
19. 19 Pruett TL. Editorial response: De novo HBV infections after liver transplantation. Liver Transpl Surg 1998 ; 5: 182–184. MEDLINE
20. 20 Delmonico FL, Snydman DR. Organ donor screening for infectious diseases. Review of practice and implications for transplantation. Transplantation 1998 ; 65: 603–610. MEDLINE
21. 21 Caldwell SH. Hard times and imperfect organs. Liver Transpl Surg 1997 ; 3: 181–184. MEDLINE
22. 22 Sheen IS, Liaw YF, Chu CM, Pao CC. Role of hepatitis C virus infection in spontaneous hepatitis surface antigen clearance during chronic hepatitis B virus infection. J Infect Dis 1992 ; 165: 831–834. MEDLINE
23. 23 Colantoni A, De Maria N, Hassaneim TI, Van Thiel DH. Management of hepatitis B pre‐ and post‐OLTx: A review and a look to the future. Viral Hepat Rev 1995 ; 2: 157–170.
24. 24 Lucey MR. Hepatitis B infection and liver transplantation: The art of the possible. Hepatology 1994 ; 19: 245–247. MEDLINE
25. 25 Gish RG, Keeffe EB, Lim J, Brooks LJ, Esquivel CO. Survival after liver transplantation for chronic hepatitis B with reduced immunosuppression. J Hepatol 1995 ; 22: 257–262. MEDLINE
26. 26 Tur Kaspa R, Burk RD, Shaul Y, Shafritz DA. Hepatitis B virus contains a glucocorticoid‐responsive element. Proc Natl Acad Sci U S A 1986 ; 83: 1627–1631. MEDLINE
27. 27 Sterneck M, Gÿnther S, Gerlach J, Naumov NV, Santantonio T, Fischer L, et al. Hepatitis B virus sequence changes evolving liver transplants recipients with fulminant hepatitis. J Hepatol 1997 ; 26: 754–756. MEDLINE
28. 28 Davies SE, Portmann BC, O'Grady JG, Aldis PM, Chaggar K, Alexander GJM, Williams R. Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis. Hepatology 1991 ; 13: 150–157. MEDLINE
29. 29 Ben‐Ari Z, Shnueli D, Mor E, Shapira Z, Tur‐Kaspa R. Beneficial effect of lamivudine in recurrent hepatitis B after liver transplantation. Transplantation 1997 ; 63: 393–396. MEDLINE
30. 30 Bain VG, Kneteman NM, Ma MM, Gutfreund K, Shapiro JA, Fischer K, et al. Efficacy of lamivudine in chronic hepatitis B patients with active viral replication and decompensated cirrhosis undergoing liver transplantation. Transplantation 1996 ; 62: 1456–1462. MEDLINE
31. 31 Honkoop P, de Man RA, Zondervan PE, Schalm SW. Histological improvement in patients with chronic hepatitis B virus infection treated with lamivudine. Liver 1997 ; 17: 103–106. MEDLINE